Select Committee · Science and Technology Committee (Commons)
Anti-microbial resistance
Status: Closed
Opened: 14 Jun 2022
Closed: 6 Jul 2022
Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Session and witnesses | Source |
|---|---|---|
| 22 Jun 2022 |
Oral evidence session
Dr Kitty Healey · Veterinary Medicines Directorate, DEFRA,
Dr Peter Jackson · Infex Therapeutics,
Dr Seamus O'Brien · Global Antibiotic Research and Development Partnership,
Professor Alison Holmes · Imperial College London,
Professor Mark Woolhouse OBE · University of Edinburgh,
Professor Robert Schooley · UC San Diego School of Medicine,
The Lord O'Neill of Gatley · The Review on Antimicrobial Resistance (2014–16)
|
View ↗ |
Who gave evidence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Witness | Organisation | Sessions |
|---|---|---|
| Dr Kitty Healey · Head of Antimicrobrial Resistance Policy and Surveillance Team | Veterinary Medicines Directorate, DEFRA | 1 |
| Dr Peter Jackson · Executive Director | Infex Therapeutics | 1 |
| Dr Seamus O'Brien · R&D Director | Global Antibiotic Research and Development Partnership | 1 |
| Professor Alison Holmes · Professor of Infectious Diseases | Imperial College London | 1 |
| Professor Mark Woolhouse OBE · Professor of Infectious Disease Epidemiology | University of Edinburgh | 1 |
| Professor Robert Schooley · Professor of Division of Infectious Diseases | UC San Diego School of Medicine | 1 |
| The Lord O'Neill of Gatley · Chair | The Review on Antimicrobial Resistance (2014–16) | 1 |
Correspondence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.